4,403,136 Shares in Humana Inc. $HUM Acquired by Pzena Investment Management LLC

Key Points

• Pzena Investment Management acquired 4.4 million Humana shares worth approximately $1.75 billion, making Humana its second-largest holding and representing a 3.67% stake.
• Humana reported quarterly EPS of $7.61, beating estimates of $7.27, while revenue rose 26.2% year over year to $40.89 billion.
• Analyst sentiment remains mixed but leans positive, with 14 Buy, 15 Hold, and one Sell rating; the consensus rating is Hold with an average price target of $395.22.

Pzena Investment Management LLC purchased a new position in Humana Inc. (NYSE:HUM - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 4,403,136 shares of the insurance provider's stock, valued at approximately $1,749,014,000. Humana comprises 5.1% of Pzena Investment Management LLC's holdings, making the stock its 2nd biggest holding. Pzena Investment Management LLC owned 3.67% of Humana as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Wilkerson Advisory Group LLC boosted its stake in shares of Humana by 24.6% during the 2nd quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider's stock worth $66,000 after acquiring an additional 33 shares in the last quarter. Bogart Wealth LLC raised its position in shares of Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider's stock worth $29,000 after purchasing an additional 48 shares during the period. Fiduciary Alliance LLC lifted its holdings in shares of Humana by 0.9% during the first quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider's stock valued at $976,000 after purchasing an additional 49 shares during the last quarter. Sanctuary Advisors LLC lifted its holdings in shares of Humana by 1.6% during the fourth quarter. Sanctuary Advisors LLC now owns 3,389 shares of the insurance provider's stock valued at $868,000 after purchasing an additional 52 shares during the last quarter. Finally, Horizon Investments LLC boosted its position in shares of Humana by 2.5% in the 4th quarter. Horizon Investments LLC now owns 2,236 shares of the insurance provider's stock valued at $573,000 after purchasing an additional 55 shares during the period. Institutional investors own 92.38% of the company's stock.

Humana Stock Performance

HUM stock opened at $383.18 on Tuesday. The firm has a 50 day simple moving average of $382.57 and a 200 day simple moving average of $277.00. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $428.88. The stock has a market cap of $46.01 billion, a P/E ratio of 36.25, a P/E/G ratio of 2.23 and a beta of 0.72. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter in the prior year, the firm earned $6.27 EPS. The company's revenue was up 26.2% compared to the same quarter last year. Research analysts anticipate that Humana Inc. will post 9.08 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Bank of America upgraded Humana from a "neutral" rating to a "buy" rating and set a $500.00 price objective on the stock in a report on Wednesday, July 29th. Jefferies Financial Group upgraded shares of Humana from a "buy" rating to a "buy" rating in a report on Wednesday, May 20th. Truist Financial lifted their target price on shares of Humana from $320.00 to $415.00 and gave the stock a "hold" rating in a research report on Tuesday, July 14th. Piper Sandler upgraded shares of Humana from a "hold" rating to an "overweight" rating and set a $463.00 price target on the stock in a report on Thursday, July 30th. Finally, Zacks Research downgraded shares of Humana from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, August 11th. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $395.22.

Humana Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source